Masuoka K. Lorianne

Insider Reports History

Location
San Carlos, CA
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Masuoka K. Lorianne:

Company Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Chief Medical Officer Stock option (right to buy) 285,000 22 Jan 2024 Direct
DiaMedica Therapeutics Inc. Chief Medical Officer Voting Common Shares, no par value per share 0 $2.80 22 Jan 2024 Direct
OPIANT PHARMACEUTICALS, INC. Director Common Stock 0 $20.00 02 Mar 2023 Direct
OPIANT PHARMACEUTICALS, INC. Director Stock Option (right to buy) 0 $10.00 02 Mar 2023 Direct

Insider Reports Filed by Masuoka K. Lorianne

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DMAC DiaMedica Therapeutics Inc. 22 Jan 2024 1 $0 4 Chief Medical Officer 23 Jan 2024, 16:23
DMAC DiaMedica Therapeutics Inc. 22 Jan 2024 0 $0 3 Chief Medical Officer 23 Jan 2024, 16:12
/report/000138550823000059-lorianne-masuoka-k-2023-03-02 OPIANT PHARMACEUTICALS, INC. 02 Mar 2023 3 -$80,000 4 Director 03 Mar 2023, 08:05
/report/000138550822000086-lorianne-masuoka-k-2022-06-14 OPIANT PHARMACEUTICALS, INC. 14 Jun 2022 1 $0 4 Director 14 Jun 2022, 16:55
/report/000138550821000084-lorianne-masuoka-k-2021-06-15 OPIANT PHARMACEUTICALS, INC. 15 Jun 2021 1 $0 4 Director 16 Jun 2021, 16:04